Kuru: The first prion disease

Advances in Experimental Medicine and Biology

Volumn 724, Issue , 2012, Pages 143-153

  Liberski, Paweł P ^a   Sikorska, Beata ^a   Brown, Paul ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANNIBALISM; CLINICAL FEATURE; CODON; ETHNOGRAPHY; GENE LOCATION; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INCIDENCE; KURU; LINKAGE ANALYSIS; MORTALITY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; AMYLOID PLAQUE; ANIMAL; GENETICS; HISTORY; PAPUA NEW GUINEA; PATHOLOGY; PHOTOGRAPHY; REVIEW;

PAN;

ANIMALS; HISTORY, 20TH CENTURY; HUMANS; KURU; PAPUA NEW GUINEA; PHOTOGRAPHY; PLAQUE, AMYLOID;

EID: 84859514120     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0653-2_12     Document Type: Article

References (69)

1. Gajdusek DC, Zigas V. Kuru. Clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among natives of the Eastern Highlands of New Papua. Am J Med 1959; 26:442-469.
2. Gajdusek DC, Zigas V. Studies of kuru. I. The ethnologic setting of kuru. Am J Trop Med Hyg 1961; 10:80-91.
3. Alpers MP, Gajdusek DC, Gibbs CJ Jr. Bibliography ofKuru. BethesdaNatl Inst Health, 1975.
4. GibbsCJJr,GajdusekDC,Asher DM etal. Creutzfeldt-Jakob disease (spongiformencephalopathy): transmission to chimpanzee. Science 1968; 161:388-389.
5. Jaskolski M, Liberski PP. Kurt Wiithrich-cowinner of the Nobel Prize in Chemistry, Acta Neurobiol Exp 2002; 62:288-289.
6. VanRossumA. Spasticpseudosclerosis(Creutzfeldt-jakobdisease). In: PJVinken,GWBruyn,eds. Handbook of ClinicalNeurology. Vol6. DiseasesofBasalGanglia.Amsterdam:North-HollandPublComp, 1968:726-760.
7. Gajdusek DC. Kuru and its contribution to medicine. Phil Trans R Soc B 2008; 363:3697-3700.
8. Mathews JD. The changing face ofkuru: a personal perspective. Phil Trans R Soc 2008; 363:3679-3684.
9. Mathews JD. The epidemiology ofkuru. Papua new Guinea Med J 1967; 10:76-82.
10. Lindenbaum S. Kuru sorcery. Disease and danger in the New Guinea Highlands. Palo Alto:Mayfield Publishing Company, 1979.
11. Gajdusek DC. Unconventional viruses and the origin and disappearance ofkuru. Science 1977; 197:943-960.
12. Zigas V, Gajdusek DC. Kuru. Clinical, pathological and epidemiological study of a recently discovered acute progressive degenerative disease of the central nervous system reaching "epidemic" proportions among natives ofthe Eastern Highlands ofNew Guinea. PNG Med J 1959; 3:1-31.
13. Zigas V. Origin of investigations on slow virus infections in man. In: SB Prusiner, Hadlow WJ, eds. Slow Transmissible Diseases of the Nervous System, vol 1. New York: Academic Press, 1979:3-6.
14. Sorenson ER, Gajdusek DC. Nutrition in the kuru region. I. Gardening, Food handling and diet of the Fore people. Acta Tropica 1969; 26:281-330.
15. Sorenson ER, Gajdusek DC. The study of child growth and development in primitive cultures. A research archive for ethnopediatric film investigations of styles in the patterning of the nervous system. Pediatrics 1966; 37 (suppl):149-243.
16. Hadlow WJ. Kuru likened to scrapie: the story remembered. Phil Trans R Soc B 2008; 363:3644.
17. Hadlow WJ. Neuropathology andthe scrapie-kuru connection. Brain Pathol 1995; 5:27-31.
18. Hadlow WJ. Scrapie and kuru. Lancet 1959; 2:289-290.
19. Hadlow WJ. The Scrapie-kuru connection: recollections of how it came about. In: Prusiner SB, Collinge J, Powell J, AndertonB, eds. Prion Diseases ofHumans and Animals. New York: Ellis Horwood, 1993:40-46.
20. Innes JRM, Saunders LZ. Comparative neuropathology, Academic Press, New York 1962; 839.
21. Goldfarb LG, Cervenakova L, Gajdusek DC. Genetic studies in relation to kuru: an overview. Curr Mol Med 2004; 4:375-384.
22. Gajdusek, telephone conversation, 2008.
23. Zlotnik I. Significance of vacuolated neurones in the medulla of sheep infected with scrapie. Nature 1957a; 180,393-394.
24. Zlotnik I. Vacuolatedneurons in sheep affected with scrapie. Nature 1957b;179,737.
25. Gibbs CJ Jr, Gajdusek DC. Attempts to demonstrate a transmissible agent in kuru, amyotrophic lateral sclerosis and other subacute and chronic progressive nervous system degenerations of man. In: Gajdusek DC, Gibbs CJ Jr, Alpers M, eds. Slow, Latent and Temperate virus infections. NINDB Monograph No. 2. US Department ofHealth, Education andWelfare, 1965:39-48.
26. Gajdusek DC, Zigas V, Baker J. Studies on kuru. III. Patterns ofkuru incidence: demographic and geographic epidemiological analysis. Am J Trop Med Hyg 1961; 10:599-627.
27. Mathews JD. Atransmissionmodel forkuru. Lancet 1967; 285:821-825.
28. Matthews JD. Kuru as an epidemic disease. In: Hornabrook RW, ed. Essays on Kuru, Papua New Guinea Inst ofMed Res Monographs no 3. Berkshire: Faringdon, 1976:83-104.
29. KlitzmanRL, Alpers MP, Gajdusek DC. The natural incubation period ofkuru andthe episodes of transmission inthree clusters ofpatients. Neuroepidemiology 1984; 3:3-20.
30. Alpers MP. Kuru: a clinical study. Mimeographed. US Dept Health, Education, Welfare 1964; 1-38.
31. Alpers MP. Kuru: age and duration studies. Mimeographed. Dept Med, Univ Adelaide 1964; 12.
32. Zigas V, Gajdusek DC. Kuru. Clinical study of a new syndrome resembling paralysis agitans in natives of the eastern Highlands of Australian new Guinea. Med J Australia 1957; 44:745-754.
33. Klatzo I, Gajusek DC, Zigas V. Evaluation of pathological findings in twelve cases ofkuru. In: Van Boagert L, Radermecker J, Hozay J, Lowenthal A, eds. Encephalitides. Amsterdam: Elsevier Publ. Comp, 1959:172-190.
34. Klatzo I, Gajusek DC. Pathology ofkuru. Lab Invest 1959; 8:799-847.
35. BeckE, Daniel PM, Alpers MP etal. Experimental kuru in chimpanzees. A pathological report. Lancet 1966; 2:1056-1059.
36. Beck E, Daniel PM, Asher DM et al. Experimental kuru in chimpanzees. A neuropathological study. Brain 1973; 96:441-462.
37. Beck E, Daniel PM, Gajdusek DC. A comparison between the neuropathological changes in kuru and scrapie, system degeneration. Proc of the VIth Int Congress Neuropathol, Zurich 1965; 213-218.
38. Beck E, Daniel PM. Kuru and scrapie compared: are they examples of system degeneration? In: Gajdusek DC, Gibbs CJ Jr., Alpers MP, eds. Slow, Latent and Temperate Virus Infections. Washington, DC: US Dept Health, Education, Welfare, 1965:85-93.
39. Beck E, Daniel PM. Prion diseases from aneuropathologist's perspective. In: Prusiner SB, Collinge J, Powell J, AndertonB, eds. Prion Diseases of Humans and Animals. New York, London, Toronto, Sydney: Singapore Ellis Horwood, 1993:63-65.
40. SeitelbergerF.Eigenartigefamiliar- hereditareKrankheitdesZetralnervensystemsineinerniederosterreichischen Sippe. Wien Klein Wochen 1962; 74:687-691.
41. Neuman MA, Gajdusek DC, Zigas V. Neuropathologic findings in exotic neurologic disorder among natives ofthe Highlands of New Guinea. J Neuropathol Exp Neurol 1964; 23:486-507.
42. Masters CL, Gajdusek DC, Gibbs CJ Jr. Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Straussler syndrome. With an analysis ofthe various forms ofamyloidplaque deposition in the virus induced spongiform encephalopathies. Brain 1981; 104:559-588.
43. Sikorska B, Liberski PP, Sobów T et al. Ultrastructural study of florid plaques in variant Creutzfeldt-Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt-Jakob disease and Gerstmann- Sträussler-Scheinker disease. Neuropathol Appl Neurobiol 2009; 35:46-59.
44. Hainfellner J, Liberski PP, Guiroy DC et al. Pathology and immunohistochemistry of a kuru brain. Brain pathol 1997; 7:547-554.
45. McLean CA, Ironside JW, Alpers MP et al. Comparative neuropathology ofkuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype ofhost. Brain Pathol 1998; 8:428-437.
46. Peat A, Field EJ. Anunusual structure inkurubrain. Acta Neuropathol (Berl) 1970; 15:288-292.
47. Liberski PP. The occurrence of cytoplasmic lamellar bodies in scrapie infected and normal hamster brains. Neuropatol. Polska 1988,26:79-85.
48. Field EJ, Mathews JD, Raine CS. Electron microscopic observations on the cerebellar cortex in kuru. JNeurol Sci 1969; 8:209-224
49. Liberski PP, Yanagihara R, Gibbs CJ, Jr et al. Re-evaluation of experimental Creutzfeldt-Jakob disease: serial studies of the Fujisaki strain of Creutzfeldt-Jakob disease virus in mice. Brain 1990; 113:121-137.
50. Goodbrand IA, Ironside JW, Nicolson D et al. Prion protein accumulations in the spinal cords of patients with sporadic and growth hormone-associated Creutzfeldt-Jakob disease. Neurosci Lett 1995;183:127-130.
51. Brandner S, Whitfield J, Boone K et al. Central andperipheral pathology ofkuru: pathological analysis of arecent case and comparison with other forms of human prion diseases. Phil Trans R Soc B 2008; 363:3755-3763.
52. Lee H-S, Brown P, Cervenakova L et al. Increased susceptibility to kuru of carriers of the PRNP129 Methionine/ Methionine genotype. J InfDis 2001; 183:192-196.
53. Cervenakova L, Goldfarb LG, Garruto R et al. Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease. Proc Natl Acad Sci USA 1998; 95:13239-13241.
54. Matthews JD, Glasse RM, Lindenbaum S. Kuru and cannibalism. Lancet 1968; 292:449-452.
55. Mead S, Poulter M, Uphill J et al. Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study. Lancet Neurology 2009; 8:57-66.
56. Mead S, Stumpf MP, Whitfield J et al. Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 2003; 300:640-643.
57. Mead S, Whitfield J, Poulter M et al. Genetic susceptibility, evolution and the kuru epdemic. Phil Trans R Soc B 2008; 363:3741-3746.
58. Mead S. Prion disease genetics. Eur J Hum Genet 2006; 14:273-81.
59. Lantos B, Bhata K, Doey LJ et al. Is the neuropathology of new variant Creutzfeldt-Jakob disease and kuru similar? Lancet 1997; 350:187-188.
60. Aguzzi A, Heikenwalder M. Prion diseases: cannibals and garbage piles. Nature 2003; 423:127-129.
61. Brookfield JF. Human evolution: a legacy of cannibalism in our genes? Curr Biol 2003; 13:R592-593.
62. Marlar RA, Leonard BL, Billman BR et al. Biochemical evidence of cannibalism at a prehistoric Puebloan site in southwestern Colorado. Nature 2000; 407:25-26.
63. Collinge CJ, Whitfield J, McKintosch E et al. Kuru in the 21st century-an acquired human prion disease with very long incubationperiods. Lancet 2006; 367:2068-2074.
64. Wadsworth JDF, Joiner S, Linehan JM et al. The origin of the prion agent ofkuru: molecular and biological strain typing. Phil Trans R Soc B 2008; 363:3747-3753.
65. Wadsworth JDF, Joiner S, Linehan JM et al. Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice.Proc Natl ACad SCi USA 2007; 105:3885-3890.
66. Collinge J, Sidle KCL, Meads J et al. Molecular analysis of prion strain variation and the etiology of "new variant" CJD. Nature 1996; 383:685-670.
67. Hill AF, Desbruslais M, Joiner S et al. The same prion strain causes vCJD andBSE. Nature 1997; 389:448-450.
68. Gibbs CJ. Spongiform encephalopathies-slow, latent and temperate virus infections-in retrospect. In: Prusiner SB, Collinge J, Powell J, Anderon B, eds. Prion Diseases of Humans and Animals. New York, London, Toronto, Sydney, Singapore: Ellis Horwood, 1993:77-91.
69. GajdusekDC.Infectiousamyloids: subacutespongiformencephalopathiesastransmissiblecerebralamyloidoses.In: BN Fields, DM Knippe, PM Howley eds. Fields Virology, 3rd ed Philadelphia: Lippincott-Raven,1996:2851-2900.